Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS · Delayed Price · Currency is USD
0.0004
+0.0001 (33.33%)
Oct 15, 2025, 1:08 PM EDT
Acura Pharmaceuticals Market Cap
Acura Pharmaceuticals has a market cap or net worth of $19.95 thousand as of October 15, 2025. Its market cap has decreased by -99.93% in one year.
Market Cap
19.95K
Enterprise Value
n/a
Revenue
1.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since March 17, 1986, Acura Pharmaceuticals's market cap has decreased from 7.10M to 19.95K, a decrease of -99.72%. That is a compound annual growth rate of -13.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 19.95K | 50.34% |
| Dec 31, 2024 | 13.27K | 100.57% |
| Dec 29, 2023 | 6.62K | -99.80% |
| Dec 30, 2022 | 3.28M | -89.93% |
| Dec 31, 2021 | 32.54M | 615.81% |
| Dec 31, 2020 | 4.55M | -7.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |